91. Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: Beyond the Baveno VI criteria. Issue 1 (16th February 2017) Authors: Tosetti, G.; La Mura, V.; Aghemo, A.; Lampertico, P.; D'Ambrosio, R.; Viganò, M.; Grossi, G.; Fraquelli, M.; Colombo, M.; Primignani, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
92. Serum markers for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment. Issue 1 (16th February 2017) Authors: Sangiovanni, A.; D'Ambrosio, R.; Lunghi, G.; Bruccoleri, M.; Alimenti, E.; Borghi, M.; Perbellini, R.; Aghemo, A.; Iavarone, M.; Colombo, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
93. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with direct acting antivirals: A prospective multicenter Italian study. Issue 1 (February 2018) Authors: Lleo, A.; Aglitti, A.; Ciancio, A.; Di Marco, V.; Aghemo, A.; Lampertico, P.; Brunetto, M.R.; Zuin, M.; Andreone, P.; Villa, E.; Troshina, G.; Calvaruso, V.; Degasperi, E.; Coco, B.; Giorgini, A.M.; Conti, F.; Di Leo, A.; Marzi, L.; Boccaccio, V.; Bollani, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
94. Systematic review with meta‐analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon‐therapy in hepatitis B infection?. Issue 6 (26th January 2014) Authors: Galmozzi, E.; Viganò, M.; Lampertico, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 6(2014) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
95. T06.01.5 DIAGNOSTIC ACCURACY OF A POCKET-SIZE ULTRASOUND DEVICE IN IDENTIFYING LIVER SURFACE NODULARITY FOR FIBROSIS STAGING IN CHRONIC LIVER DISEASE. (1st October 2020) Authors: Costantino, A.; Piagnani, A.; Donato, F.; Maggioni, M.; Lampertico, P.; Vecchi, M.; Fraquelli, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
96. Temporal trends of access to DAAs treatments for HCV in the Navigatore-Lombardia network: Evolution of AIFA criteria, DAA regimens and patient features. Issue 1 (February 2018) Authors: Pasulo, L.; Aghemo, A.; Rizzardini, G.; Rossotti, R.; Vinci, M.; Spinetti, A.; Filice, G.; Grossi, P.; Ciaccio, A.; Colombo, M.; Lampertico, P.; Fagiuoli, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
97. Tenofovir Alafenamide improves proximal tubular markers in CHB patients long-term treated with Tenofovir Disoproxil Fumarate: A real-life study based on the EASL switching criteria. (March 2021) Authors: Loglio, A.; Viganò, M.; Borghi, M.; Gentile, C.; Facchetti, F.; Sambarino, D.; Perbellini, R.; Soffredini, R.; Renteria, SC. Uceda; Rumi, MG.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
98. The combination of IFN-lambda-4 and HLA-DPB1 polymorphisms accurately predict HBsAg loss in IFN treated genotype D HBeAg-negative patients with chronic hepatitis B. (10th February 2016) Authors: Lampertico, P.; Galmozzi, E.; Facchetti, F.; Cheroni, C.; Invernizzi, F.; Valveri, V.; Soffredini, R.; Viganò, M.; Abrignani, S.; De Francesco, R.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
99. The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years. (February 2019) Authors: Loglio, A.; Galmozzi, E.; Iavarone, M.; Facchetti, F.; Viganò, M.; Perbellini, R.; Segato, S.; Filippi, E.; Rumi, M.G.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
100. The HSD17B13 rs6834314 variant is associated with liver stiffness measurement in untreated HCV-3 patients with cirrhosis. (February 2020) Authors: Galmozzi, E.; Facchetti, F.; Perbellini, R.; D'Ambrosio, R.; Degasperi, E.; Soffredini, R.; Borghi, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗